FNY Investment Advisers’s abrdn Life Sciences Investors HQL Stock Holding History

FNY Investment Advisers’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,600	Closed	-$20K	–	839
2024 Q4	$20K	Buy	+1,600	New	+$23.1K	0.01%	428
2021 Q4	–	Sell	-1,500	Closed	-$31K	–	666
2021 Q3	$31K	Buy	+1,500	New	+$32.1K	0.01%	430
2021 Q1	–	Sell	-1,776	Closed	-$35K	–	890
2020 Q4	$35K	Buy	1,776 +1,770	+29,500%	+$32.7K	0.01%	450
2020 Q3	$0	Buy	+6	New	+$107	﹤0.01%	540
2020 Q1	–	Sell	-4,203	Closed	-$73K	–	611
2019 Q4	$73K	Buy	+4,203	New	+$69K	0.02%	411
2018 Q3	–	Sell	-675	Closed	-$12K	–	1063
2018 Q2	$12K	Buy	+675	New	+$12.7K	﹤0.01%	416

Other funds holding HQL

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

AIA

Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return

FNY Investment Advisers's HQL Position: Q1 2025 in Review

FNY Investment Advisers sold out of abrdn Life Sciences Investors (HQL) in Q1 2025, closing a stake of 1,600 shares — an estimated $20K sold.

FNY Investment Advisers first reported a position in HQL in Q2 2018 and held it in 6 quarters. The position peaked at $73K in Q4 2019. 82 funds tracked by Wall St. Rank hold HQL as of Q1 2025.

FNY Investment Advisers reported no remaining abrdn Life Sciences Investors position as of Q1 2025 after selling out during the quarter.
FNY Investment Advisers sold 1,600 abrdn Life Sciences Investors shares in Q1 2025, an estimated $20K.
FNY Investment Advisers first reported a position in abrdn Life Sciences Investors in Q2 2018 and held it in 6 quarters.
FNY Investment Advisers's abrdn Life Sciences Investors position peaked at $73K in Q4 2019.
82 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2025.

Based on FNY Investment Advisers's 13F filing for Q1 2025, filed 17 Apr 2025.